# US 2008/0076158 A1 · Process for the fermentative production of proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076158 A1
- Document ID: US20080076158A1
- Status: Published application
- Kind: A1
- Application number: 11/859,350
- Filed: 2007-09-21
- Published: 2008-03-27
- Earliest claimed: 2006-09-22
- Assignees: Wacker Chemie AG
- Inventors: Tobias Dassler; Anneliese Reutter-Maier; Guenter Wich
- Web page: https://patentgrep.com/patent/US20080076158A1

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C07K 14/56: IFN-alpha
- C07K 16/36: against blood coagulation factors
- C07K 16/40: against enzymes
- C12N 9/1074: {Cyclomaltodextrin glucanotransferase (2.4.1.19)}
- C12Y 204/01019: Cyclomaltodextrin glucanotransferase (2.4.1.19)
- C07K 2317/55: Fab or Fab'
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present invention relates to a process for producing a heterologous protein by means of an E. coli strain in a fermentation medium, in which an E. coli strain which has a mutation in the lpp gene or in the promoter region of the lpp gene, and contains a gene coding for a heterologous protein which is functionally linked to a signal sequence coding for a signal peptide, is fermented on an industrial scale in the fermentation medium, with the E. coli strain secreting the heterologous protein into the fermentation medium, and the protein being removed from the fermentation medium, wherein the heterologous protein comprises more than 70 amino acids.

## Claims

### Claim 1

A method for producing a heterologous protein by utilizing an E. coli strain in a fermentation medium, the method comprising:
a) fermenting an E. coli strain in a fermentation medium such that the E. coli strain secretes the heterologous protein into the fermentation medium, the E. coli strain having:
a mutation in the lpp gene or in the promoter region of the lpp gene, and
a gene coding for a heterologous protein which is functionally linked to a signal sequence coding for a signal peptide; and
b) removing the protein from the fermentation medium, wherein the heterologous protein comprises more than 70 amino acids.

### Claim 2 (depends on 1)

The method of claim 1, wherein the mutation in the lpp gene is a substitution, a deletion or an insertion of one or more nucleotides in the lpp gene or in the promoter region of the lpp gene, leading to the lpp gene no longer being expressed or being expressed to only a reduced extent, or leading to an altered amino acid sequence of the Lpp protein which is associated with a reduction in the functionality of the Lpp protein.

### Claim 3 (depends on 1)

The method of claim 1, wherein the mutation in the lpp gene brings about replacement of the arginine residue at position 77 of SEQ ID NO: 2 by a cysteine residue (lpp1 mutants) leading to the cells exhibiting an increased leakiness for periplasmic proteins.

### Claim 4 (depends on 1)

The method of claim 1, wherein the mutation in the lpp gene brings about a replacement of the glycine residue at position 14 of SEQ ID NO: 2 by an aspartic acid residue (lpp3 mutants) leading to the cells exhibiting an increased leakiness for periplasmic proteins.

### Claim 5 (depends on 1)

The method of claim 1, wherein the mutation in the lpp gene includes a deletion of at least one nucleotide in the lpp gene itself or in the promoter region of the lpp gene leading to the cells exhibiting an increased leakiness for periplasmic proteins.

### Claim 6 (depends on 1)

The method of claim 1, wherein the protein comprises one or more disulfide bridges or is in its functional form a dimer or multimer.

### Claim 7 (depends on 1)

The method of claim 1, wherein the heterologous protein is a eukaryotic protein.

### Claim 8 (depends on 7)

The method of claim 7, wherein the eukaryotic protein is an antibody or antibody fragment, a cytokine, a growth factor, a protein kinase or a protein hormone.

### Claim 9 (depends on 7)

The method of claim 7, wherein an antibody fragment is produced in an extracellular yield of more than 1 g/l.

### Claim 10 (depends on 6)

Method for the secretion of a protein consisting of several subunits according to claim 6, wherein the gene coding for a signal peptide is selected from the group of consisting of genes coding for the signal sequence of the phoA or ompA gene of E. coli and the signal sequence having SEQ ID NO: 3.

### Claim 11 (depends on 10)

The method of claim 10, wherein the 5′ end of the gene of the protein subunit to be produced is linked in frame to the 3′ end of a signal sequence for protein export, with the genes of different subunits of the protein being linked to different signal sequences.

### Claim 12 (depends on 1)

The method of claim 1, wherein the fermentation takes place in a fermenter with a volume of more than 5 l.

### Claim 13 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Ca2+ ions in a concentration greater than 4 mg/l.

### Claim 14 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Ca2+ ions in a concentration from above 4 mg/l to 5000 mg/l,

### Claim 15 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Ca2+ ions in a concentration from 10 mg/l to 5000 mg/l.

### Claim 16 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Ca2+ ions in a concentration from 40 mg/1-5000 mg/l.

### Claim 17 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Mg2+ ions in a concentration greater than 48 mg/l.

### Claim 18 (depends on 1)

The method of claim 1, wherein the fermentation medium comprises Mg2+ ions in a concentration from above 48 mg/l to 5000 mg/l.

### Claim 19 (depends on 1)

The method of claim 1, wherein the fermentation medium is a minimal salt medium.

### Claim 20 (depends on 1)

The method of claim 1, wherein the fermentation takes place over a period of from 24 to 72 hours.

### Claim 21

An isolated E. coli strain having a mutation in the lpp gene or in the promoter region of the lpp gene, the isolated E. coli strain comprising a recombinant gene coding for a eukaryotic protein to be secreted and functionally linked to a gene coding for a signal peptide which is active in E. coli, the eukaryotic protein having more than 70 amino acids.

### Claim 22 (depends on 21)

The E. coli strain of claim 21, wherein the recombinant gene is provided with expression signals functional in E. coli.

### Claim 23 (depends on 21)

The E. coli strain of claim 21, wherein the recombinant gene include a promoter, a transcription start, translation start, a ribosome binding site, and a terminator.
